The Institute of Medicinal Molecular Design (IMMD), Inc. announced today that the European Molecular Biology Laboratory (EMBL) has licensed IMMD's KeyMolnet, the next-generation bioinformatics platform. EMBL will use KeyMolnet for research activities at the main laboratory in Heidelberg, Germany and at its outstations.
